Summary of main endpoints in the three included trials versus other trials
| Trial | Follow-up duration | Occlusion metric | Parent vessel stenosis | Retreatment | Imaging modality | Core laboratory | 100% occlusion rate (%) |
| ATLAS, WEB-IT, LVIS | 1 year | 100% occlusion | >50 stenosis | Evaluated | DSA | Yes | |
| WEBCAST | 6 months | 100% occlusion or stable neck remnant | Not evaluated | Evaluated | DSA | Yes | 56 |
| WEBCAST 2 | 1 year | Not specified | Not evaluated | Evaluated | DSA 78% | Expert independently evaluated | 54 |
| CLARYS | 1 year | RR 1 | Not evaluated | Evaluated | 65% DSA | Yes | 41 |
ATLAS, Safety and Effectiveness of the Treatment of Wide Neck, Saccular Intracranial Aneurysms With the Neuroform Atlas Stent System; CLARYS, CLinical Assessment of WEB device in Ruptured aneurYSms; LVIS, Pivotal Study of the Low Profile Visualized Intraluminal Support; WEBCAST, WEB Clinical Assessment of Intrasaccular Aneurysm Therapy; WEB-IT, Woven EndoBridge Intrasaccular Therapy Study.